Synthesis and pharmacological validation of a novel radioligand for the orphan GPR88 receptor
- 29 December 2022
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 80, 129120
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (R01AA026820, R03AA029013)
This publication has 28 references indexed in Scilit:
- Synthesis, Pharmacological Characterization, and Structure–Activity Relationship Studies of Small Molecular Agonists for the Orphan GPR88 ReceptorACS Chemical Neuroscience, 2014
- Development of [3H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([3H]PSB-12150): A Useful Tool for Studying GPR17ACS Medicinal Chemistry Letters, 2014
- Association study in three different populations between the GPR88 gene and major psychosesMolecular Genetics & Genomic Medicine, 2013
- Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviorsNature Neuroscience, 2012
- GPR88: A putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulationBasal Ganglia, 2011
- Radioligand Binding Methods for Membrane Preparations and Intact Cells2011
- Ligand binding assays at equilibrium: validation and interpretationBritish Journal of Pharmacology, 2010
- The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders?Molecular and Cellular Neuroscience, 2009
- Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferentsEuropean Journal of Neuroscience, 2009
- A Novel G-Protein-Coupled Receptor Gene Expressed in StriatumGenomics, 2000